Kimberly-Clark Co. (NYSE:KMB) Position Trimmed by RKL Wealth Management LLC

RKL Wealth Management LLC reduced its position in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) by 60.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,460 shares of the company's stock after selling 3,722 shares during the period. RKL Wealth Management LLC's holdings in Kimberly-Clark were worth $350,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Kimberly-Clark by 15.1% during the 4th quarter. Vanguard Group Inc. now owns 35,142,545 shares of the company's stock worth $4,605,079,000 after buying an additional 4,603,787 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Kimberly-Clark by 5.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 10,589,967 shares of the company's stock valued at $1,387,709,000 after acquiring an additional 529,223 shares during the period. Geode Capital Management LLC grew its position in shares of Kimberly-Clark by 10.4% during the fourth quarter. Geode Capital Management LLC now owns 8,473,459 shares of the company's stock worth $1,113,444,000 after acquiring an additional 797,953 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Kimberly-Clark by 5.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,529,108 shares of the company's stock worth $986,616,000 after acquiring an additional 417,118 shares during the period. Finally, Invesco Ltd. lifted its position in Kimberly-Clark by 21.9% in the 4th quarter. Invesco Ltd. now owns 5,653,751 shares of the company's stock valued at $740,868,000 after purchasing an additional 1,015,141 shares during the last quarter. 76.29% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. UBS Group raised their price target on shares of Kimberly-Clark from $134.00 to $146.00 and gave the company a "neutral" rating in a research note on Thursday, April 17th. Piper Sandler cut their target price on Kimberly-Clark from $158.00 to $156.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Wells Fargo & Company increased their price target on Kimberly-Clark from $130.00 to $140.00 and gave the stock an "equal weight" rating in a research note on Friday, March 28th. JPMorgan Chase & Co. raised their price target on Kimberly-Clark from $124.00 to $131.00 and gave the company an "underweight" rating in a report on Friday, April 11th. Finally, Barclays decreased their target price on shares of Kimberly-Clark from $139.00 to $135.00 and set an "equal weight" rating for the company in a research report on Thursday, April 24th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Kimberly-Clark currently has a consensus rating of "Hold" and a consensus target price of $143.50.

Kimberly-Clark Price Performance

Kimberly-Clark stock traded up $0.75 during mid-day trading on Wednesday, hitting $132.36. The company's stock had a trading volume of 2,137,913 shares, compared to its average volume of 2,203,216. The stock has a market capitalization of $43.92 billion, a P/E ratio of 17.53, a P/E/G ratio of 4.46 and a beta of 0.35. Kimberly-Clark Co. has a twelve month low of $124.10 and a twelve month high of $150.45. The stock's fifty day moving average price is $134.28 and its two-hundred day moving average price is $134.72. The company has a quick ratio of 0.54, a current ratio of 0.80 and a debt-to-equity ratio of 7.05.

Kimberly-Clark (NYSE:KMB - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.89 by $0.04. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%. The business had revenue of $4.84 billion for the quarter, compared to analysts' expectations of $4.90 billion. During the same period in the previous year, the firm posted $2.01 EPS. Research analysts forecast that Kimberly-Clark Co. will post 7.5 earnings per share for the current year.

Kimberly-Clark Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 2nd. Stockholders of record on Friday, June 6th will be given a $1.26 dividend. This represents a $5.04 annualized dividend and a dividend yield of 3.81%. The ex-dividend date is Friday, June 6th. Kimberly-Clark's dividend payout ratio (DPR) is currently 68.66%.

Insider Activity

In related news, insider Katy Chen sold 740 shares of the firm's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $129.70, for a total value of $95,978.00. Following the completion of the transaction, the insider owned 3,997 shares of the company's stock, valued at approximately $518,410.90. This trade represents a 15.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.64% of the stock is owned by corporate insiders.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.